CARD || Lipid & Metabolic Disorders

Evolocumab lowers LDL-C with no effect on glucose metabolism

Posted on: 17/05/2014 - 15:00

LAS VEGAS – Evolocumab, an investigational antibody that inhibits PCSK9, reduces levels of low-density lipoprotein cholesterol in hypercholesterolemic patients who have dysglycemia or metabolic...

Field of Interest: Endocrinology

Type: News Item

Complication rates decline among diabetes patients

Posted on: 16/04/2014 - 22:00

The rate of diabetes-related myocardial infarction has fallen almost 68% since 1990, according to an analysis of several federal data sources. From 1990 to 2010, the rate of acute MI among adults...

Field of Interest: Endocrinology

Type: News Item

Diabetes prevalence increases, but so does diabetes control

Posted on: 14/04/2014 - 22:00

The prevalence of diagnosed diabetes in the United States rose significantly from 1988 to 2010, jumping from 6% to 10%. Prediabetes doubled in prevalence over the same time period, from 6% to 12%,...

Field of Interest: Endocrinology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Evolocumab lowers LDL-C with no effect on glucose metabolism

Complication rates decline among diabetes patients

Diabetes prevalence increases, but so does diabetes control

Newsletters

Latest Newsletters